NCT01305577 - Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental Fat | Biotech Hunter

Enrollment

363

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions

Moderate or Severe Submental Fullness

Interventions

DRUG

Deoxycholic acid injection

DRUG

Placebo

Phosphate buffered saline placebo for injection

Trial Locations (30)

9700

Investigational Site, Oudenaarde

10117

Investigational Site, Berlin

14469

Investigational Site, Potsdam

42275

Investigational Site, Wuppertal

60590

Investigational Site, Frankfurt am Main

62000

Investigational Site, Arras

64297

Investigational Site, Darmstadt

67061

Investigational Site, Ludwigshafen

75005

Investigational Site, Paris

75010

Investigational Site, Paris

76829

Investigational Site, Landau

80337

Investigational Site, München

82319

Investigational Site, Starnberg

86163

Investigational Site, Augsburg

86179

Investigational Site, Augsburg

93500

Investigational Site, Pantin

06400

Investigational Site, Cannes

06202

Investigational Site, Nice

D-37154

Investigational Site, Northeim

08017

Investigational Site, Barcelona

08022

Investigational Site, Barcelona

08028

Investigational Site, Barcelona

08034

Investigational Site, Barcelona

SW1 9QN

Investigational Site, London

M6 8HD

Investigational Site, Salford

NN4 7BU

Investigational Site, Northampton

NG3 7DQ

Investigational Site, Nottingham

NG9 8AR

Investigational Site, Nottingham

PL6 8BX

Investigational Site, Plymouth

GL50 1QZ

Investigational Site, Cheltenham